Open access
379
Views
9
CrossRef citations to date
0
Altmetric
Review
Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps
Nuzhat Afroz1 Patient Access Services, Novartis Healthcare Private Limited, Hyderabad, IndiaCorrespondence[email protected]
https://orcid.org/0000-0002-3048-2704
, https://orcid.org/0000-0002-3048-2704
Florian S Gutzwiller2 Global Patient Access, Novartis Pharma AG, Basel, Switzerlandhttps://orcid.org/0000-0001-7754-5744
, Alex J Mackay3 National Heart and Lung Institute, Imperial College London, London, UK;4 Global Medical Affairs and Drug Development, Novartis Pharma AG, Basel, Switzerland
, Christel Naujoks2 Global Patient Access, Novartis Pharma AG, Basel, Switzerlandhttps://orcid.org/0000-0002-3799-6521
, Francesco Patalano5 Clinical Development and Analytic, Global Drug Development, Novartis Pharma AG, Basel, Switzerlandhttps://orcid.org/0000-0001-7015-6084
& Konstantinos Kostikas6 Respiratory Medicine Department, University of Ioannina, Ioannina, Greece;7 Global Medical Affairs, Respiratory, Novartis Pharma AG, Basel, Switzerlandhttps://orcid.org/0000-0003-0774-3942
Pages 1789-1800
|
Published online: 23 Jul 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.